USA Purchases 100 Million COVID-19 Vaccines for $1.95 Billion

BioNTech SE and Pfizer Inc. announced today the U.S. government had exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine known as Comirnaty. This order increases the total number of vaccine doses to be supplied by these companies to the U.S. government to 300 million.

Consistent with the agreements for the prior 200 million doses, the U.S. government will pay $1.95 billion for the additional 100 million doses.

“It is our objective to supply as many doses of our COVID-19 vaccine as possible to people in order to help end this pandemic, reduce the hospitalization of especially elderly people and bring us back to our normal lives,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech, in a press statement issued on February 12, 2021.

Pfizer’s facility in Kalamazoo, MI, remains the primary manufacturing site of the Pfizer-BioNTech COVID-19 vaccine in the USA.